USP “Key Drug Types” Could Serve As CMS Standard For Medicare Rx Plans

The U.S. Pharmacopeia hopes its list of "formulary key drug types" will become the CMS standard for reviewing the appropriateness of Medicare Rx plans' drug lists

More from Archive

More from Pink Sheet